A New Paradigm Shift: Parts 1 and 2 (Pages 25-31)
DUE TO THE AGING OF THE population, most of our population will spend roughly half of their lives as presby-opes. The etiology of presby-opia has been poorly understood, and treatment options have failed to address the true issues with the disease, creating compro mises in vision that patients are eager to find a solution for, not expecting to have their daily lives affected. There is both an overlooked etiology regarding the mechanism of presbyopia in the medical community, as well as a lack of awareness in the presbyopic population in general. If we are to be successful in implementing presbyopic solutions that address the pathogenesis, onset, and progressive compounding of the clinical manifestations that accompany presbyopia, there must be an effort toward shifting the paradigm of education and awareness toward the real issues that provoke this elusive age-related disease.
Explore More Articles
Laser Vision: Pioneering Laser Innovations for Presbyopia ft. Ace Vision’s Dr. AnnMarie Hipsley
In this episode, Ayesha spoke with AnnMarie Hipsley, DPT, PhD, CEO and founder of Ace Vision Group, an ophthalmic laser device company that is bringing touchless eye laser therapy to patients with age-related vision loss. Dr. Hipsley is a vision scientist, inventor, entrepreneur, author and speaker on ocular biomechanics and the biomechanical rejuvenation of the aging …
read moreDynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read moreVESA prediction tool could help guide presbyopia treatment
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, speaks about the Virtual Eye Simulation Analyzer, a device with predictive diagnostic capabilities. VESA uses ray tracing technology to analyze lens changes and biomechanics related to accommodation and disaccommodation, visualizing them in virtual reality and predicting …
read more